RESUMO
Regional lymphotropic therapy used in complex treatment of patients with new-onset pulmonary tuberculosis enhances its efficiency. It is well tolerated by patients and easy-to-use. The pharmacokinetic feature of isoniazid during its lymphotropic administration is its shorter elimination half-life, decreased total clearance, and a larger area under the pharmacokinetic curve.
Assuntos
Antituberculosos/farmacocinética , Antituberculosos/uso terapêutico , Isoniazida/farmacologia , Isoniazida/uso terapêutico , Linfonodos/metabolismo , Tuberculose Pulmonar/tratamento farmacológico , Adulto , Antituberculosos/administração & dosagem , Esquema de Medicação , Feminino , Humanos , Isoniazida/administração & dosagem , MasculinoAssuntos
Hipersensibilidade a Drogas/diagnóstico , Adulto , Animais , Antituberculosos/efeitos adversos , Antituberculosos/uso terapêutico , Fenômenos Biofísicos , Biofísica , Gatos , Hipersensibilidade a Drogas/metabolismo , Quimioterapia Combinada , Feminino , Humanos , Medições Luminescentes , Masculino , Pessoa de Meia-Idade , Tuberculose Pulmonar/tratamento farmacológico , Tuberculose Pulmonar/metabolismoRESUMO
Materials on testing of urine and blood serum by chemiluminometry (CLM) for diagnosis of adverse reactions to drugs in patients with tuberculosis are presented. Urine and blood serum from 94 patients with pulmonary tuberculosis were tested. The group included 59 patients with allergic, toxico-allergic and toxic reactions to the antituberculous drugs used in their treatment, 17 patients with satisfactory tolerance of the treatment and 18 patients subjected to the tests prior to their treatment. The diagnostic value of the urine tests was rather high (84.7 per cent) and not inferior to that of the blood serum tests (86.4 per cent). The simultaneous testing of both the media increased the frequency of detecting the sensitizing drug. The procedure is simple, not harmful for the patients and provides rapid results (20-30 minutes) and objective estimation. It may be recommended for the use in medical institutions.